Macmillan Research Advisory Panel

Read more about the current members of our Research Advisory Panel below.

Dr Ajay Aggarwal

Ajay Aggarwal is a Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Foundation Trust, London. He is an Honorary Senior Lecturer in the Institute of Cancer Policy at King’s College London. His main research areas are health services research, clinical epidemiology and global health. Since 2013, he has been the Oncology Coordinator for the National Prostate Cancer Audit (NPCA), which aims to assess the processes and outcomes of care for all newly diagnosed prostate cancer patients in the NHS. As part of this work, he has developed outcome indicators using administrative datasets to assess the quality of radiotherapy and surgical treatment at the individual patient and hospital level.

In 2017, he completed an NIHR Doctoral Research Fellowship at the London School of Hygiene and Tropical Medicine (LSHTM). There, he explored the role of hospital competition in the delivery of NHS cancer services using mixed methods. He has previously worked at the World Health Organisation (WHO) in Geneva. He has ongoing global health projects in Ghana and Tanzania, that are aimed at building radiotherapy capacity and research capability.

Dr Stephen Barclay

Stephen Barclay is University Senior Lecturer in Palliative Care and General Practice at the University of Cambridge. His work in general practice and hospice settings informs his research into palliative and end of life care, particularly in community and general practice. He leads medical student teaching in palliative care in Cambridge, and has a research interest in medical education in palliative care. He leads the Cambridge Palliative & End of Life Care Group, which includes doctors, nurses, psychologists, statisticians and social scientists and uses a range of research methods. This includes qualitative, quantitative, mixed methods and systematic literature reviews.

Alan Bateman

Alan Bateman is a patient representative on the panel. He was successfully treated for head and neck cancer in 2007. He divides his time between running an IT consultancy company and working with Macmillan and the East of England Cancer Alliance. He is a trainer and facilitator for Macmillan and specialises in the HOPE course, which provides a self-help framework for those living with and beyond cancer.

For Cancer Alliances, he manages the Quality of Life pilot and works with the Cancer Information Centre in Ipswich NHS Trust. He was a Non-Executive Director on the Trust Board for eight years, four of these as Deputy Chair. He had specific responsibility for the Finance & Performance Committee. In his professional career, he has managed substantial research programmes. He has many years’ experience of reviewing investment proposals and evaluating their potential benefits and pitfalls.

Karen Forbes

Karen Forbes is a Consultant in Palliative Medicine. She is one of three consultants in the palliative care team at University Hospitals Bristol NHS Trust. It is a multidisciplinary team, supporting staff in providing general palliative care for patients and advising on patients with complex or specialist palliative care needs. The team sees inpatients on all UH Bristol wards and has a weekly outpatient clinic. She liaises closely with St Peter's Hospice staff, who provide community palliative care input once patients are discharged from hospital.

Karen is also a professor at the University of Bristol. She runs the palliative care and oncology teaching for the final year of the medical undergraduate programme, and is currently final year lead. She also runs a Master’s programme in Palliative Medicine.

Professor Diana Greenfield

Diana Greenfield is a registered nurse with a quantitative methods PhD. She is dual qualified in oncology and endocrinology and has further qualifications in education and advanced practice. She is Honorary Professor in Cancer Survivorship in the Department of Oncology and Metabolism, University of Sheffield. Her clinical expertise is in late effects anticipatory care for those who have had a stem cell transplant. She is also experienced with haematological cancers, young adults with solid tumours and transitional care for childhood cancer survivors into adult services. She promotes recovery and optimising health and wellbeing after cancer, by leading and influencing the improvement of aftercare services for cancer patients locally, regionally and nationally.

Her principal academic interests are the physical and psychological late treatment consequences in survivors of cancer treatment. This includes metabolic syndrome, returning to work and physical activity after cancer, models of follow-up and care after cancer treatment, and cancer care workforce competences.

Dr Yoryos (Georgios) Lyratzopoulos

Yoryos (Georgios) Lyratzopoulos is Reader in Cancer Epidemiology at University College London (UCL), and a Cancer Research UK Advanced Clinician Scientist Fellow. He is affiliated with the University of Cambridge and Public Health England's National Cancer Registration and Analysis Service. His research focuses on the predictors and outcomes of diagnostic timeliness in cancer patients, based on experiences. He was NIHR Post-Doctoral Fellow (2012-2014) and has worked for the NHS England and NICE as a hospital doctor and public health physician.

As of December 2016, he has published 130 peer-reviewed papers, two thirds of which as first/last author. Yoryos holds the Cancer Research UK Future Leaders Prize in Cancer Research (2016), which recognises individuals who have demonstrated the potential to achieve world-leading status, by producing research of international importance in their first ten post-doctoral years.

Professor Roma Maguire

Roma Maguire is a Professor of Digital Health and Care at the University of Strathclyde. She also holds an Honorary Nurse Consultant post at NHS Lanarkshire. Her research interests include digital health, cancer care, dementia, long-term care management, patient experience, supportive care, predictive risk modelling and implementation science. She has significant experience in the development and evaluation of supportive care and digital health interventions and has led several multi-site clinical trials in the UK and Europe. She is Principal Investigator of the EU FP7 eSMART study which is evaluating the impact of a mobile phone based remote patient monitoring system on chemotherapy related toxicity.

Professor Tim Peters

Tim Peters is Professor of Primary Care Health Services Research and Head of the School of Clinical Sciences at the University of Bristol. He is also Research Director for the Faculty of Health Sciences. He is a statistician and trialist with over 30 years’ experience of epidemiology and research on health and health services, specialising in primary care. His research interests focus on community-based evaluations of health interventions. Many of these evaluations involve randomised trials conducted by multidisciplinary research teams, including quantitative and qualitative methodologists.

Tim has also conducted research on the methodology of trials. This includes randomising groups of individuals (cluster trials) and exploring the extent to which interventions benefit certain individuals more than others (subgroup analyses). A further priority has been the development and supervision of researchers from a variety of backgrounds. He has supported 20 doctoral degrees undertaken by doctors, nurses, health care professionals and research methodologists.

John Rouse

John Rouse advises on research projects in many areas of medicine, from a patient and public perspective. Following the death of his wife from melanoma, John became a member of an NCRI Clinical Studies Group (CSG), the local cancer network, and a NICE Guideline Development Group. He was a patient and public voice on the 100,000 Genomes Project and is now doing the same for GeNEQ, the Laboratory Reconfiguration project. John works closely with groups in the UK and Europe. He is a retired IT consultant.

Professor Peter C. Smith

Peter C. Smith is Emeritus Professor of Health Policy at Imperial College Business School. Smith is a mathematics graduate from the University of Oxford. He started his academic career in the Department of Public Health and Primary Care at University of Cambridge. His main research has been in the economics of health and public finance. He was a Director of the Centre for Health Economics at the University of York. He has acted in numerous UK governmental advisory capacities and is currently chair of the NHS Advisory Committee on Resource Allocation. He advised many overseas governments and international agencies, including the World Health Organisation (WHO), the International Monetary Fund (IMF), the World Bank, the European Commission and the Organisation for Economic Cooperation and Development. He continues to research actively on the economic aspects of health systems and global health, including the economics of cancer care.

Alison Walters

Alison Walters is a retired educational consultant. She has been involved with Macmillan and local cancer services in the North West for the last seven years. The catalyst was the extraordinary quality of support received from a Macmillan nurse and community services that allowed her to nurse her terminally ill husband at home despite challenging and complicated symptoms. Alison's interests are in the quality of palliative and end of life care and the importance of honest communication.

Professor Mary Wells

Mary Wells is a cancer nurse with a clinical academic background. Her research is focused on health services in oncology, and supportive care for people with cancer. This includes the needs, experiences and outcomes of people who have completed treatment. She has methodological expertise in qualitative research and the development and evaluation of complex interventions. Mary works closely with cancer charities to improve experiences, outcomes and practices. She was a member of the Executive Board of the European Oncology Nursing Society (EONS) from 2009-2015, and served as Secretary from 2011-2015. She now co-chairs the EONS Research Working Group.

Since 2009, she has been a specialist advisor to Macmillan and the Consequences of Cancer Treatment Collaborative. She is on the Clinical Advisory Board of the Throat Cancer Foundation. In 2016, Mary was appointed as a trustee of HealthTalk (previously DiPeX). She has been a member of the NCRI Psychosocial Oncology and Survivorship Clinical Studies Group (CSG) since 2013 and has led the interventions sub-group since 2015. She is a member of the survivorship sub-group of the Head and Neck CSG. Mary has extensive grant reviewing experience for a range of bodies, including the NIHR, Cancer Research UK, the Chief Scientist Office and NHS R&D boards. She reviews for numerous journals and is an Associate Editor of the European Journal of Oncology Nursing.

Pete Wheatstone

Pete is an experienced Patient and Public Involvement (PPI) member who works with a number of UK cancer charities, Public Health England (PHE) and other bodies and projects. Through family, friends and personal experience, Pete understands the effects that cancer can have on patients, carers, family members and on small businesses. As a retired IT Consultant, Pete spent much of his career working with both large IT companies and his own consultancy companies on major business software implementations and business transformation programmes for financial services conglomerates, in the UK and Europe.